Sanofi, Formation Bio, OpenAI Announce AI Collaboration
(RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Tuesday a collaboration with Formation Bio and AI research and deployment company OpenAI to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Under the deal, the companies would bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle.
Sanofi said it will leverage the partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.